BEIJING, April 16, 2026 /PRNewswire/ — Yiren Digital Ltd. (NYSE: YRD) (“Yiren Digital” or the “Company”), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced its inclusion in the S&P Global Sustainability Yearbook (China Edition) 2026. Alongside this milestone, Yiren Digital was also honored with the “Industry Mover” distinction. The Yearbook is widely regarded as one of the most comprehensive annual publications evaluating corporate sustainability performance in China.

The recognition reflects Yiren Digital’s performance in the 2025 S&P Global Corporate Sustainability Assessment (CSA), where the Company scored 50 out of 100, placing Yiren Digital in the top decile of the “Diversified Financial Services and Capital Markets” industry globally as of October 24, 2025, reflecting a 12-point improvement over the prior year. For the 2026 China Edition, nearly 1,800 companies were assessed, with only approximately 190 selected for inclusion. Yiren Digital was further honored with the “Industry Mover” distinction, recognizing the Company as the strongest year-over-year ESG performer in its industry. The Company delivered meaningful gains across key ESG dimensions, including a 6-point increase in governance and a 10-point increase in social performance. S&P Global classified the Company’s overall data availability as High relative to industry peers.

“Our inclusion in the S&P Global Sustainability Yearbook (China Edition) 2026 reflects a conviction at the heart of our business: that a strong ESG strategy is inseparable from a strong fintech strategy,” said Mr. Ning Tang, Chairman and Chief Executive Officer of Yiren Digital. “AI-powered risk management and information security are not simply compliance boxes to check; they are how we earn and keep the trust of the customers we serve. Expanding financial inclusion for underserved borrowers and small business owners is central to our mission. This recognition underscores that sustainable value creation and commercial growth are mutually reinforcing, and we will continue to build on that foundation.”

Yiren Digital’s Key Achievements in the 2025 Corporate Sustainability Assessment

Yiren Digital delivered strong performance across both the Social and Governance & Economic dimensions. The Social Dimension was Yiren Digital’s strongest-performing dimension, with the Company achieving a score of 55/100, significantly ahead of the industry average of 24/100. The Governance & Economic Dimension also improved year over year, with performance exceeding industry averages across Risk & Crisis Management, Business Ethics and Information Security.

These results reflect the Company’s continued focus on embedding risk management, data security and financial inclusion into its core operating model.

Yiren Digital’s ESG Framework

Yiren Digital has established a three-tier ESG governance framework comprising a Board-level ESG Committee, management-level oversight, and an ESG working group. This structure integrates sustainability considerations into corporate strategy, business operations and risk management.

The Company has set targets to reach peak carbon emissions by 2030 and achieve net-zero greenhouse gas emissions from its own operations by 2060. In 2025, Yiren Digital published its second consecutive annual ESG Report alongside three ESG-related core policies, including its Occupational Health and Safety Policy, further strengthening its ESG disclosure framework. The Company’s ESG reporting now covers more than 90 sub-topics aligned with CSA evaluation criteria.

About Yiren Digital

Yiren Digital Ltd. is a leading fintech company specializing in digital consumer lending, insurance, and financial technology innovation across China and global markets. The Company leverages advanced artificial intelligence and emerging technologies to enhance customer experience, optimize capital efficiency, and expand financial inclusion. With the successful filing of the in-house developed Large Language Model Zhiyu, the substantial upgrade of its Magicube Agent platform, Yiren Digital is establishing a new growth engine to position itself as an AI-powered next-generation fintech leader. For more information, please visit https://ir.yiren.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “target,” “confident,” and similar expressions.

Forward-looking statements are based on management’s current expectations, assumptions, and assessments of current market and operating conditions. These statements involve inherent risks, uncertainties, and other factors, many of which are outside the control of Yiren Digital Ltd. (NYSE: YRD) (the “Company”), and which could cause actual results to differ materially from those expressed or implied in such statements.

Such risks and uncertainties include, but are not limited to, significant fluctuations in loan origination volumes, changes in credit performance and delinquency trends, variations in take rates and monetization efficiency, availability and cost of funding, and the Company’s ability to achieve its anticipated financial results or previously issued guidance.

In addition, the Company operates in a highly regulated industry in the People’s Republic of China (“PRC”), and its business is materially affected by the evolving regulatory framework applicable to credit facilitation, consumer finance, online lending-related services, data security, and financial risk management. Regulatory policies and implementation measures in these areas have undergone, and may continue to undergo, significant and rapid changes, including changes in interpretation and enforcement.

Such regulatory developments may include, but are not limited to, adjustments to risk retention and capital requirements, restrictions on pricing, interest rates, or service fees, enhanced consumer protection and compliance obligations, data privacy and cybersecurity requirements, and limitations on certain business models or partnership structures. These measures may materially impact the Company’s ability to originate loans, maintain relationships with funding partners, price its services competitively, or sustain historical revenue and profitability levels.

Furthermore, the timing, scope, and enforcement intensity of regulatory changes in the PRC are often uncertain and may vary across regions and over time. Such uncertainty may result in increased compliance costs, operational constraints, and strategic adjustments, and may also affect funding partner behavior, borrower demand, and overall industry liquidity.

In addition, shifts in regulatory policy and market expectations may adversely affect investor sentiment and capital market conditions for the industry, potentially resulting in reduced loan facilitation volumes, increased volatility in financial performance, and pressure on margins.

Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors, including, but not limited to, unexpected changes in regulatory policies or enforcement practices, macroeconomic conditions, borrower credit behavior, funding partner participation, competitive dynamics, and other risks described in the Company’s filings with the U.S. Securities and Exchange Commission.

All forward-looking statements speak only as of the date of this press release. The Company undertakes no, and expressly disclaims any, obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable law.

FOSHAN, China, April 16, 2026 /PRNewswire/ — YIZUMI is strengthening its global manufacturing presence through continued engineering investment, expanding international operations, and a broader portfolio of advanced molding technologies. With capabilities spanning injection molding, die casting, rubber injection, automation, and thixomolding, the company is building a more connected platform for customers seeking precision, efficiency, and long-term production value.

This forward-looking direction will also take center stage at YIZUMI CONNECT 2026, which will be held from April 20 to 24, 2026 in Nanxun, Zhejiang, China, under the theme “Evolve Beyond Limits.” Designed around manufacturing technology, innovation, and industry collaboration, the event will serve as an important platform for showcasing YIZUMI‘s latest developments and broader strategic direction.

Expanding Global Manufacturing Strength

Founded in 2002, YIZUMI has grown into a world-class manufacturer of mid-to-high-end molding equipment and a leading provider of turnkey solutions. With over 5,000 employees and more than 140,000 machines operating globally, our production footprint spans nearly 800,000 square meters. This massive scale creates a robust foundation for advanced product development, manufacturing excellence, and international delivery.

That expanding global base is being matched by a larger industry presence. At YIZUMI CONNECT 2026, visitors will experience an over 61,000 m² smart factory, reflecting the company’s growing scale and its ambition to present a broader, more immersive showcase environment.

Engineering Innovation Driving Long-Term Growth

Technology remains central to YIZUMI’s long-term development. Average annual R&D investment exceeds CNY 200 million, and the company has developed more than 400 patented technologies across core equipment categories. An integrated product development model continues to support faster iteration, product upgrades, and the commercialization of new technologies.

This engineering foundation is helping YIZUMI move further into higher-value manufacturing segments, while also shaping the content of YIZUMI CONNECT 2026. The event will not only highlight equipment and solutions, but also strengthen industry dialogue through strategy launches, technology forums, and other programs focused on future manufacturing trends.

A Broader Platform for Modern Industry

YIZUMI’s product lineup now covers multiple major manufacturing processes, giving customers access to more complete production solutions under one brand. Major categories include injection molding machines, die casting machines, rubber injection molding machines, robotic automation systems, thixomolding solution, 3D-Printing, and Yi+Platform.

This multi-technology platform will be reflected throughout the event program. In addition to product and solution displays, YIZUMI CONNECT 2026 will feature a Summit Roundtable, a YIZUMI Strategy Launch, and 8 Innovation Zones, creating a more layered experience that combines product presentation, strategic communication, and themed technology showcases.

Next-Gen A6 Series for Intelligent Hydraulic Injection Molding

The Next-Gen A6 Series Advanced and Intelligent Injection Molding Machine reflects YIZUMI’s latest direction in hydraulic injection molding. Designed for modern production environments, the A6 Series combines intelligent control, energy efficiency, precision, and stable output in one platform.

Key features include:

• Clamping forces from 900 to 18,500 kN
• Built on the IPD 2.0 process
• Developed around intelligence, green performance, precision, and efficiency
• Designed for stable performance in demanding molding applications

FF Series for High-Precision Electric Injection Molding

The FF Series Electric Injection Molding Machine highlights YIZUMI’s strength in electric molding technology. This series is aimed at applications that require tighter process control, higher consistency, and smoother integration with automation systems.

Key features include:

• Clamping forces from 150 to 13,800 kN
• Supports seamless automation and intelligent integration
• Suited for parts with higher requirements in thickness, precision, and structural complexity
• Applied in medical, auto parts, 3C electronics sectors

LEAP Series for Advanced Die Casting

The LEAP Series Die Casting Machine represents YIZUMI’s continued push into higher-end die casting applications. Built for demanding production environments, the LEAP Series is designed to improve repeatability, control, and overall operating performance.

Key features include:

• Locking forces from 3,800 kN to 10,000 kN
• Upgrades in injection, control, locking, and energy-saving systems
• Equipped with Yi-Cast real-time closed-loop control technology
• Designed to improve overall equipment effectiveness in complex die-casting operations

YIZUMI CONNECT 2026 to Spotlight Innovation and Industry Connection

One of the signature moments of the event will be the debut of YIZUMI i-Factory (Nanxun), positioned as a major highlight of the overall program. Together with the Strategy Launch, the debut adds stronger forward-looking and industry-facing value to the event, extending it beyond a traditional equipment exhibition.

With its expanded exhibition area, featured launches, roundtable agenda, and innovation-focused displays, YIZUMI CONNECT 2026 is shaping up to be a high-visibility industry event that reflects both YIZUMI’s current capabilities and its next stage of development.

Looking Ahead

YIZUMI’s current trajectory points to a more connected and more technically advanced global manufacturing platform. A wider international presence, deeper engineering capability, and a steadily expanding product lineup are all pushing YIZUMI further into the global advanced manufacturing market.

As that momentum continues, YIZUMI CONNECT 2026 will offer customers, partners, and industry professionals a concentrated view of where the company is heading next—and how its technologies are evolving to support the future of manufacturing.

CONTACT: 
Roxy
Branding Management
Yizumi Holdings Co. Ltd.
Email: yizumicompany@gmail.com 
Website: https://www.yizumi.com/en

• The explosion of healthcare-focused LLMs and chatbots has given patients greater access to health information, but the accuracy of results and patient trust are falling short

• Built on the company’s Symptom Checker, Consult provides a clinically-validated and medically supported option to help guide patients to the right care

• Ubie’s platform has seen rapid adoption by consumers, with over 13 million monthly users (2 million in the US) in March 2026 and 25% month-over-month growth

NEW YORK, April 16, 2026 /PRNewswire/ — Ubie, an AI-driven and clinically vetted healthcare prediction platform that guides patients to the care they need, today announced the launch of Consult, the company’s doctor-approved, chat-based LLM developed specifically for healthcare. The new platform, which is built on top of the company’s clinically-validated Symptom Checker, is free to use and supports patients in deciding whether to self-manage or seek care, while also helping explain pre-existing diagnoses. The ultimate goal for the platform is to empower patients to take action and follow appropriate steps in their care, not to diagnose or prescribe.

It’s well known that patients are increasingly turning to LLM-based chatbots as a resource for health information. OpenAI, which developed ChatGPT, reports that 3 in 5 US adults use AI for health purposes. And while trust in AI is increasing, a majority of people (56%) are not confident that they can tell the difference between true and false AI responses. This raises serious concerns over the use of untested digital tools for self-diagnosis.

Recently, a large number of healthcare-focused LLMs have become available, but they have yet to prove trustworthy, especially for patients who might have serious medical conditions or need urgent care. Studies have shown the need for more rigorous trials before systems can be deployed for widespread use.

• Findings from a University of Oxford study show a major gap between the promise of LLMs and their actual usefulness in giving medical advice.
• In a different study, 1,298 participants were asked to use an LLM, such as ChatGPT or Meta’s Llama 3, for medical advice. Results show that the LLMs correctly identified medical conditions in fewer than 34.5% of cases.
• Outcomes from a study published in Nature show that ChatGPT Health “under-triaged” half of medical emergencies from clinically authored vignettes.

Ubie’s platform, which is used by more than 15 million people worldwide every month, is trained on more than 50,000 peer-reviewed publications, leverages a panel of more than 50 medical specialists for accuracy, and is connected to more than 1,800 healthcare provider organizations for real-world feedback.

Built on this foundation, Consult is designed to interact with patients through conversational dialogue, smart buttons, photo uploads, OTC advice, and trusted routing to appropriate medical attention. It can help patients get the information they need to make a care decision, such as monitoring conditions, visiting a doctor, going to the ER, or checking with a pharmacist for an over-the-counter medication.

“People are becoming accustomed to interacting with AI and chatbots on a daily basis, which is positive, but currently comes with too much risk,” said Kota Kubo, co-founder and co-CEO of Ubie. “Ubie Consult provides a trusted, highly accurate, medically-validated option that gives patients the information they need about their symptoms and ensures they get appropriate guidance and care.”

Chatbots and health-focused LLMs are helping to close gaps in healthcare access and equity by providing 24/7, low-cost, and scalable care alternatives, particularly for underserved, marginalized, or rural populations. But it’s important that digital tools are both accurate and trustworthy. Consult provides insights into symptoms and the best next steps for care before patients ignore potential issues or rush to urgent care or a specialist.

Ubie has seen rapid growth as more and more patients look for credible online sources of health information, with more than 2 million people in the US interacting with the platform in March 2026 and 25% month-over-month growth.

Consult was designed to closely mirror the structure and pacing of talking to a doctor, while ensuring patients don’t leave with more questions than they came with. Most importantly, the platform gives people answers they can trust because every pathway has been reviewed and validated by physicians.

Ubie’s Consult can be found at: https://ubiehealth.com/consult/

About Ubie

Ubie is a healthcare AI company powering clinical-grade, AI-first patient journeys. While general-purpose AI focuses on information, Ubie provides doctor-approved direction, guiding users safely from initial symptoms to actionable treatment. Backed by Google and global partners, Ubie combines proprietary disease-prediction AI with a HIPAA-ready “safety layer” to support digital front-door experiences and chronic disease management.

Globally, Ubie guides over 15 million monthly users, including 2 million in the U.S. In Japan, Ubie’s provider solutions support more than 1,800 healthcare organizations, clinical expertise now being scaled for U.S. health systems to provide the safest, most reliable bridge between patient symptoms and professional care.

Learn more about our vision and work at https://ubiehealth.com/company.

Media Contact

Rob Mazzini
Mazzini Public Relations
Rob@mazzinipublicrelations.com

• Piramal Pharma Solutions is a global leader in antibody-drug conjugate (ADC) development and manufacturing, leveraging over 20 years of specialized experience to support partners from early-stage to commercialization.
• Ajinomoto Bio-Pharma Services is a leading provider of biopharmaceutical manufacturing services and platform technologies, responsible for the development of AJICAP™, a set of proprietary technologies designed to facilitate the creation of site-specific ADCs and linkers.
• Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs.

MUMBAI, India and TOKYO, April 16, 2026 /PRNewswire/ — Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), and Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical manufacturing services and platform technologies, have announced a strategic collaboration.

Under this collaboration, Piramal will refer applicable customers seeking ADC manufacturing technology to Aji Bio-Pharma and AJICAP™. Aji Bio-Pharma will refer Piramal to customers as a potential CDMO for manufacturing products using AJICAP™ technology, supporting their programs across development and manufacturing.

Following the execution of this agreement, Piramal and Ajinomoto will enter into a separate Material Transfer Agreement (MTA) to allow the transfer of technology between companies. The MTA will equip Piramal with the expertise, capabilities, and personnel for it to manufacture AJICAP™-based products with precision and speed.

As the world’s first FDA-approved ADC CDMO, Piramal brings over two decades of experience to the field. The Company also pioneered commercial ADC manufacturing, earning it more than 15 years of specialized expertise. With a global network of state-of-the-art facilities, Piramal has developed hundreds of ADCs, completed thousands of batches, and currently manufactures multiple commercial ADCs. Ongoing expansions are increasing Piramal’s commercial-scale ADC capacity.

Ajinomoto’s AJICAP™ technology facilitates the development of site-specific ADCs and linker technologies through simple, efficient processes, empowering early-stage pharmaceutical developers to create ADCs with higher efficacy and lower toxicity. Pairing this innovative platform with Piramal’s clinical and commercial ADC GMP manufacturing expertise enables customers to accelerate development, streamline tech transfer, and simplify scale-up.

“We are excited to collaborate with Ajinomoto Bio-Pharma Services and enhance our ADC platform by offering manufacturing support for AJICAP™-based products,” said Peter DeYoung, CEO, Piramal Global Pharma. “With the implementation of these capabilities, we will accelerate innovation and expand access to this technology for our customers and their patients worldwide.”

“This collaboration with Piramal expands the ecosystem supporting AJICAP™ technology by connecting licensed customers with an experienced ADC manufacturing partner,” said Yasuyuki Otake, Corporate Executive, General Manager, Bio-Pharma Services Dept., Ajinomoto Co., Inc. “Through this collaboration, we aim to provide our customers with streamlined pathways and access to deep ADC expertise to advance high-quality programs from early development through commercial manufacturing.”

By combining AJICAP™’s site-specific conjugation technology with Piramal’s extensive development and manufacturing expertise, this collaboration will help customers deliver safe, effective, and precise ADC therapies with exceptional efficiency.

About Piramal Pharma Solutions

Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process and pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products and services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines and gene therapies, made possible through Piramal Pharma Limited’s associate company, Yapan Bio Private Limited.

For more information visit: Piramal Pharma Solutions | LinkedIn | Facebook | X

About Piramal Pharma Limited

Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the Piramal Consumer Healthcare business, selling over-the-counter consumer and wellness products. In addition, one of PPL’s associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics/bio-therapeutics and vaccine segments.

For more information, visit: Piramal Pharma | LinkedIn

^{* Includes one facility via PPL’s minority investment in Yapan Bio.}

About Aji Bio-Pharma Services

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, India, Japan, and United States, providing support across gene therapy, APIs, and both large and small molecule manufacturing. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including high potency APIs (HPAPI), continuous flow manufacturing, oligonucleotide synthesis, biocatalysis, Corynex® protein expression technology, antibody drug conjugations (ADC) and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our clients’ needs. Learn more: www.AjiBio-Pharma.com

Logo: https://laotiantimes.com/wp-content/uploads/2026/04/piramal_pharma_solutions_logo.jpg
Logo: https://laotiantimes.com/wp-content/uploads/2026/04/ajinomoto_logo.jpg

SHANGRAO, China, April 16, 2026 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS), a global leader in clean energy technology, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.

Fourth Quarter and Full Year 2025 Business Highlights

• Module shipments for full year 2025 were 86 GW, ranking first in the industry.
• By the end of the fourth quarter, we became the first module manufacturer in the world to deliver a total of over 390 GW solar modules, with total shipments of the Tiger Neo series surpassing 220 GW, making it the best-selling module series in history.
• Our N-type TOPCon-based perovskite tandem solar cell achieved a new conversion efficiency record of 34.76%.
• By the end of the fourth quarter, we had been granted over 700 TOPCon patents, surpassing most competitors on the N-type TOPCon patent list.
• Full-year energy storage system shipments increased significantly year-over-year, achieving the targets we set at the beginning of the year, while our presence in overseas markets continued to expand.
• We were recognized as a Tier 1 energy storage provider by Bloomberg New Energy Finance (BNEF) for the eighth consecutive quarter.

Fourth Quarter 2025 Operational and Financial Highlights

• Quarterly solar modules shipments were 24,204 MW, up 20.9% sequentially and down 4.0% year-over-year.
• Total revenues were RMB17.51 billion (US$2.50 billion), up 8.3% sequentially and down 15.2% year-over-year.
• Gross profit was RMB55.1 million (US$7.9 million), down 95.3% sequentially and 93.0% year-over-year.
• Gross margin was 0.3%, compared with 7.3% in Q3 2025 and 3.8% in Q4 2024.
• Net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders was RMB1.50 billion (US$214.5 million), compared with net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders of RMB749.8 million in Q3 2025 and net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders of RMB476.7 million in Q4 2024.
• Adjusted net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders was RMB837.7 million (US$119.8 million), which excludes the impact of (i) the change in fair value of convertible notes issued by Jinko Solar Co., Ltd. (“Jiangxi Jinko”) in 2023, (ii) the change in fair value of long-term investment, (iii) share-based compensation expenses, and (iv) the impairment of long-lived assets, compared with adjusted net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders of RMB373.1 million in Q3 2025 and adjusted net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders of RMB430.8 million in Q4 2024.
• Basic and diluted losses per ordinary share were RMB7.16 (US$1.02) and RMB7.16 (US$1.02), respectively. This translates into basic and diluted losses per ADS of RMB28.65 (US$4.10) and RMB28.65 (US$4.10), respectively.

Full Year 2025 Operational and Financial Highlights

• Annual solar modules shipments were 86,056 MW, down 7.3% year-over-year.
• Total revenues were RMB65.50 billion (US$9.37 billion), down 29.0% year-over-year.
• Gross profit was RMB1.41 billion (US$201.7 million), down 86.0% year-over-year.
• Gross margin of 2.2%, compared with 10.9% for the full year of 2024.
• Net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders was RMB4.45 billion (US$635.6 million), down 8,250.2% year-over-year.
• Adjusted net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders was RMB3.14 billion (US$448.6 million), which excludes the impact of (i) the change in fair value of convertible notes issued by Jiangxi Jinko in 2023, (ii) the change in fair value of long-term investment, (iii) share based compensation expenses, (iv) the net loss resulting from the fire accident that occurred at one of our silicon wafer slicing and solar cell manufacturing workshops in Shanxi Province in 2024 (the “Fire Accident”), and (v) the impairment of long-lived assets, compared with adjusted net income attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders of RMB521.9 million in 2024.
• Basic and diluted losses per ordinary share were RMB21.33 (US$3.05) and RMB21.33 (US$3.05), respectively. This translates into basic and diluted losses per ADS of RMB85.31(US$12.20) and RMB85.31 (US$12.20), respectively.

Mr. Xiande Li, JinkoSolar’s Chairman and Chief Executive Officer, commented, “Global module shipments reached 86 GW in 2025, ranking first globally for the seventh consecutive year. The global photovoltaic industry continued to experience volatility due to structural imbalances and a shifting trade environment, which negatively impacted financials across the industrial chain. Facing persistently low module prices, the elimination of obsolete production capacity, and a still-evolving product mix, we incurred a net loss for the full year. In the fourth quarter, our gross margin decreased sequentially and our net loss expanded, impacted by factors including rising costs of raw materials such as polysilicon and silver, as well as foreign exchange rate fluctuations. However, our energy storage business maintained its rapid growth trajectory, with shipments growing significantly year-over-year, marking an important step in our ongoing transformation into an integrated energy solutions provider. We expect our ESS shipments to more than double in 2026 compared to 2025, as we penetrate into more high-value markets.

The Chinese government has continued to strengthen its recent policies supporting the high-quality development of the industry. These policies are guiding the industry away from pure competition on scale and price toward a focus on genuine quality and value. In response, leading companies have been actively support government initiatives to return module prices to reasonable levels. In the first quarter of 2026, this dynamic, combined with the pass-through of rising commodity prices such as silver, as well as the impact of export tax rebates on demand, drove a significant sequential rebound in module prices. As the competitive landscape normalizes and supply—demand dynamics gradually improve, we expect module prices to remain relatively stable going forward, with high efficiency and differentiated products continuing to command a premium. Simultaneously, volatility in global energy markets has highlighted the critical need for energy security, reinforcing the long-term value of reliable renewable energy. As solar power generation enters a market-driven phase, industry competition is transitioning to a model centered on technological innovation, product competitiveness, and the ability to deliver integrated solar plus storage solutions—which we are uniquely positioned to capitalize on.

We continue to drive technological breakthroughs and lead industry innovation, highlighting the quality and value we offer. As of the end of the fourth quarter, we became the first module manufacturer in the world to deliver a total of over 390 GW of solar modules, with cumulative shipments of our Tiger Neo series surpassing 220 GW, making it the best-selling module series in history. As of the end of 2025, the maximum laboratory conversion efficiency of our N-type TOPCon cells reached 27.79%, while our N-type TOPCon-based perovskite tandem solar cell achieved a new conversion efficiency record of 34.76%. Our development of silver-coated copper technology is progressing as planned, with large-scale production expected to gradually ramp up in 2026. We also continue to drive product upgrades, with shipments of high-efficiency products that exceed 640 W during the quarter increasing sequentially to approximately 3 GW. As we scale up production of our Tiger Neo 3.0 series this year, the differentiated value proposition of our high-efficiency products will allow us to command higher premiums. Further supporting this is our vertically integrated production model which continues to improve production efficiency and cost competitiveness.

As the global energy transition advances and the demand for grid flexibility increases, the role of energy storage within renewable energy systems continues to strengthen. Looking forward to the medium to long term, as the construction of new power systems advances and new load demand grows from data centers, application scenarios for solar and storage systems will continue to broaden. To address growing customer demand, we continued to optimize our global manufacturing and supply chain footprint. Our 2 GW N-type module facility in the U.S. maintained high utilization rates as we further strengthened local manufacturing and service capabilities there.

Looking forward, we will continue to consolidate our technological leadership, deepen our global footprint, accelerate the development of our integrated solar + storage solutions, and consistently improve our capabilities to deliver comprehensive value through our solutions. This will steadily strengthen our long-term competitiveness and profitability as the industry landscape reshapes. With this in mind, we expect annual integrated production capacity to reach approximately 100 GW by the end of 2026, including 14 GW from overseas facilities. We expect module shipments to be between 13 GW and 14 GW for the first quarter of 2026, and between 75 GW and 85 GW for the full year 2026.”

Fourth Quarter 2025 Financial Results

Total Revenues

Total revenues in the fourth quarter of 2025 were RMB17.51 billion (US$2.50 billion), representing an increase of 8.3% from RMB16.16 billion in the third quarter of 2025 and a decrease of 15.2% from RMB20.65 billion in the fourth quarter of 2024. The sequential increase was primarily due to the increase in the shipment volume of solar modules, while the year-over-year decrease was mainly due to the decrease in the average selling price of solar modules.

Gross Profit and Gross Margin

Gross profit in the fourth quarter of 2025 was RMB55.1 million (US$7.9 million), compared with RMB1.18 billion in the third quarter of 2025 and RMB789.7 million in the fourth quarter of 2024.

Gross margin was 0.3% in the fourth quarter of 2025, compared with 7.3% in the third quarter of 2025 and 3.8% in the fourth quarter of 2024. The sequential decrease was primarily due to a higher unit cost of products sold, while the year-over-year decrease was mainly due to the decrease in the average selling price of solar modules.

Loss from Operations and Operating Margin

Loss from operations in the fourth quarter of 2025 was RMB3.26 billion (US$465.7 million), compared with loss from operations of RMB1.40 billion in the third quarter of 2025 and loss from operations of RMB1.94 billion in the fourth quarter of 2024. The sequential and year-over-year increases were primarily attributable to the decrease in our gross margin in the fourth quarter of 2025.

Operating loss margin was 18.6% in the fourth quarter of 2025, compared with operating loss margin of 8.7% in the third quarter of 2025 and operating loss margin of 9.4% in the fourth quarter of 2024.

Total operating expenses in the fourth quarter of 2025 were RMB3.31 billion (US$473.6 million), representing an increase of 28.0% from RMB2.59 billion in the third quarter of 2025 and an increase of 21.2% from RMB2.73 billion in the fourth quarter of 2024. The sequential and year-over-year increases were primarily due to an increase in the impairment of long-lived assets in the fourth quarter of 2025.

Total operating expenses accounted for 18.9% of total revenues in the fourth quarter of 2025, compared to 16.0% in the third quarter of 2025 and 13.2% in the fourth quarter of 2024.

Interest Expenses and Interest Income

Interest expenses were RMB359.0 million (US$51.3 million), and interest income was RMB129.3 million (US$18.5 million) in the fourth quarter of 2025.

Net interest expenses in the fourth quarter of 2025 were RMB229.7 million (US$32.8 million), representing an increase of 13.8% from RMB201.8 million in the third quarter of 2025 and a decrease of 1.9% from RMB234.3 million in the fourth quarter of 2024. The sequential increase was primarily due to an increase of interest-bearing debt in the fourth quarter of 2025, while the year-over-year decrease was mainly due to an increase of interest income during the fourth quarter of 2025.

Subsidy Income

Subsidy income in the fourth quarter of 2025 was RMB240.4 million (US$34.4 million), compared with RMB358.6 million in the third quarter of 2025 and RMB900.1 million in the fourth quarter of 2024. The sequential and year-over-year decreases were primarily attributable to the decreases in cash receipt of incentives related to the Company’s business operations.

Exchange Loss/Gain and Change in Fair Value of Foreign Exchange Derivatives

The Company recorded a net exchange loss (including change in fair value of foreign exchange derivatives) of RMB303.8 million (US$43.4 million) in the fourth quarter of 2025, compared to a net exchange gain of RMB0.9 million in the third quarter of 2025 and a net exchange gain of RMB408.2 million in the fourth quarter of 2024. The sequential and year-over-year changes were mainly attributable to fluctuations in the exchange rate of the US dollar and euro against RMB in the fourth quarter of 2025.

Change in Fair Value of Long-term Investment

The Company holds certain equity interests in several solar technology companies in the photovoltaic industry, which are recorded as long-term investment and available-for-sale securities and reported at fair value with changes in fair value recognized as gains or losses. As of December 31, 2025, the Company had RMB864.4 million (US$123.6 million) in available-for-sale securities and long-term investment (excluding the investments accounted for under the equity method and held-to-maturity debt securities), compared with RMB1.15 billion as of September 30, 2025.

The Company recognized a loss from the change in fair value of long-term investment of RMB23.7 million (US$3.4 million) in the fourth quarter of 2025, compared with a gain of RMB60.7 million in the third quarter of 2025 and a gain of RMB332.3 million in the fourth quarter of 2024. The sequential and year-over-year changes were primarily due to the decreases in the fair value of several solar technology companies we invested in.

Other Income/Loss, Net

Net other income in the fourth quarter of 2025 was RMB26.0 million (US$3.7 million), compared with net other loss of RMB121.1 million in the third quarter of 2025 and net other loss of RMB758.4 million in the fourth quarter of 2024. The sequential and year-over-year changes were mainly due to the changes in the fair value of financial instruments in the fourth quarter of 2025.

Equity in Loss/Income of Affiliated Companies

The Company indirectly holds equity interests in several affiliated companies engaged in solar business, which are accounted for using the equity method. The Company recorded equity in loss of affiliated companies of RMB33.8 million (US$4.8 million) in the fourth quarter of 2025, compared with equity in income of affiliated companies of RMB2.9 million in the third quarter of 2025 and equity in loss of affiliated companies of RMB119.2 million in the fourth quarter of 2024. The fluctuations in equity in loss or income of affiliated companies primarily arose from the changes in net losses or gains incurred by the affiliated companies.

Income Tax Benefit

The Company recorded an income tax benefit of RMB1.04 billion (US$148.9 million) in the fourth quarter of 2025, compared with income tax benefit of RMB191.6 million in the third quarter of 2025 and income tax benefit of RMB580.5 million in the fourth quarter of 2024.

Net Loss Attributable to Non-Controlling Interests

Net loss attributable to non-controlling interests amounted to RMB1.06billion (US$152.0 million) in the fourth quarter of 2025, compared with net loss attributable to non-controlling interests of RMB385.8 million in the third quarter of 2025 and RMB370.2 million in the fourth quarter of 2024. The sequential and year-over-year increases were mainly attributable to the increases in net loss of Jiangxi Jinko, the Company’s majority-owned principal operating subsidiary.

Net Loss and Losses per Share

Net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders was RMB1.50 billion (US$214.5 million) in the fourth quarter of 2025, compared with net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders of RMB749.8 million in the third quarter of 2025 and RMB476.7 million in the fourth quarter of 2024.

Excluding the impact of (i) the change in fair value of convertible notes issued by Jiangxi Jinko in 2023, (ii) the change in fair value of the long-term investment, (iii) share-based compensation expenses, and (iv) the impairment of long-lived assets, adjusted net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders was RMB837.7 million (US$119.8 million) in the fourth quarter of 2025, compared with adjusted net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders of RMB373.1 million in the third quarter of 2025 and RMB430.8  million in the fourth quarter of 2024.

Basic and diluted losses per ordinary share were RMB7.16 (US$1.02) and RMB7.16 (US$1.02), respectively, in the fourth quarter of 2025, compared to basic and diluted losses per ordinary share of RMB3.58 and RMB3.58, respectively, in the third quarter of 2025, and basic and diluted losses per ordinary share of RMB2.32 and RMB2.32, respectively, in the fourth quarter of 2024. As each ADS represents four ordinary shares, this translates into basic and diluted losses per ADS of RMB28.65 (US$4.10) and RMB28.65 (US$4.10), respectively, in the fourth quarter of 2025; basic and diluted losses per ADS of RMB14.32 and RMB14.32, respectively, in the third quarter of 2025; and basic and diluted losses per ADS of RMB9.28 and RMB9.28, respectively, in the fourth quarter of 2024.

Full Year 2025 Financial Results

Total Revenues

Total revenues for full year 2025 were RMB65.50 billion (US$9.37 billion), representing a decrease of 29.0% from RMB92.26 billion for full year 2024. The decrease in total revenues was mainly attributable to the decrease in average selling price of solar modules.

Gross Profit and Gross Margin

Gross profit for full year 2025 was RMB1.41 billion (US$201.7 million), a decrease of 86.0% from RMB10.06 billion for full year 2024. The year-over-year decrease was mainly attributable to the decrease in average selling price of solar modules in 2025.

Gross margin was 2.2% for full year 2025, compared with 10.9% for full year 2024. The year-over-year decrease was mainly attributable to the decrease in average selling price of solar modules.

Loss from Operations and Operating Margin

Loss from operations for full year 2025 was RMB8.91 billion (US$1.27 billion), compared with loss from operations of RMB3.34 billion for full year 2024. Operating loss margin for full year 2025 was 13.6%, compared with operating loss margin of 3.6% for full year 2024.

Total operating expenses for full year 2025 were RMB10.32 billion (US$1.48 billion), a decrease of 23.0% from RMB13.40 billion for full year 2024. As a percentage of total revenues, operating expenses accounted for 15.8% for full year 2025, compared with 14.5% for full year 2024. The decrease in total operating expenses was primarily due to (i) a reduction in shipping cost, driven by lower solar module shipment volumes and a decline in average freight rate in 2025, and (ii) lower employee compensation costs in 2025.

Interest Expenses and Interest Income

Interest expenses were RMB1.36 billion (US$194.5 million), and interest income was RMB504.1 million (US$72.1 million) for the full year 2025.

Net interest expenses for full year 2025 was RMB856.0 million (US$122.4 million), an increase of 17.5% from RMB728.4 million for full year 2024. The increase was mainly due to an increase in interest-bearing debts in 2025.

Subsidy Income

Subsidy income for full year 2025 was RMB1.15 billion (US$164.0 million), compared with RMB2.45 billion for full year 2024. The year-over-year decrease was mainly attributable to a decrease in the cash receipt of incentives to the Company’s business operations.

Exchange Loss/Gain and Change in Fair Value of Foreign Exchange Derivatives

The Company recorded a net exchange loss (including change in fair value of foreign exchange derivatives) of RMB89.6 million (US$12.8 million) for full year 2025, which was primarily due to the depreciation of the US dollar and euro against RMB. The Company recorded a net exchange gain (including change in fair value of foreign exchange derivatives) of RMB601.0 million for full year 2024. The year-over-year change was mainly driven by the exchange rate fluctuations of the US dollar and euro against RMB in 2025.

Change in Fair Value of Long-term Investment

The Company holds certain equity interests in several solar technology companies in the photovoltaic industry, which are recorded as long-term investment and available-for-sale securities and reported at fair value with changes in fair value recognized as gains or losses. As of December 31, 2025, the Company had RMB864.4 million (US$123.6 million) in available-for-sale securities and long-term investment (excluding the investments accounted for under the equity method and held-to-maturity debt securities), compared with RMB1.05 billion as of December 31, 2024. The Company recognized a gain from change in fair value of long-term investment of RMB33.2 million (US$4.7 million) for full year 2025, compared to a gain of RMB163.5 million for full year 2024.

Other Loss/Income, net

Net other loss for full year 2025 was RMB512.9 million (US$73.3 million), compared with net other income of RMB796.3 million for full year 2024. The decrease was primarily due to income generated from the disposal of a wholly-owned subsidiary in 2024.

Equity in Loss of Affiliated Companies

The Company indirectly holds equity interests in several affiliated companies engaged in solar business, which are accounted for using the equity method. The Company recorded equity in loss of affiliated companies of RMB147.9 million (US$21.1 million) in 2025, compared with equity in loss of affiliated companies of RMB177.0 million in 2024. The fluctuations in equity in loss of affiliated companies primarily arose from the changes in net losses incurred by the affiliated companies.

Income Tax Benefit/Expense, Net

The Company recognized an income tax benefit of RMB2.22 billion (US$317.6 million) in 2025, compared with an income tax expense of RMB69.4 million in 2024.

Net Loss/Income and Losses/ Earnings per Share

Net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders in 2025 was RMB4.45 billion (US$635.6 million), compared with a net income attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders of RMB54.5 million in 2024.

Excluding the impact of (i) the change in fair value of convertible notes issued by Jiangxi Jinko in 2023, (ii) the change in fair value of the long-term investment, (iii) share based compensation expenses, (iv) the net loss resulting from the Fire Accident, and (v) the impairment of long-lived assets, adjusted net loss attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders was RMB3.14 billion (US$448.6 million), compared with adjusted net income attributable to JinkoSolar Holding Co., Ltd.’s ordinary shareholders of RMB521.9 million in 2024.

Basic and diluted losses per share for full year 2025 were RMB21.33 (US$3.05) and RMB21.33 (US$3.05), respectively, compared to basic earnings per share of RMB0.26 and diluted losses per share of RMB1.27, respectively, for full year 2024. This translates into basic and diluted losses per ADS of RMB85.31 (US$12.20) and RMB85.31 (US$12.20), respectively, for full year 2025, compared to basic earnings per ADS of RMB1.04 and diluted losses per ADS of RMB5.06, respectively, for full year 2024.

Financial Position

As of December 31, 2025, the Company had RMB22.94 billion (US$3.28 billion) in cash, cash equivalents, and restricted cash, compared with RMB27.74 billion as of December 31, 2024.

As of December 31, 2025, the Company’s accounts receivables were RMB13.59 billion (US$1.94 billion), compared with RMB14.07 billion as of December 31, 2024.

As of December 31, 2025, the Company’s inventories were RMB14.48 billion (US$2.07 billion), compared with RMB12.51 billion as of December 31, 2024.

As of December 31, 2025, the Company’s total interest-bearing debts were RMB47.01 billion (US$6.72 billion), compared with RMB40.59 billion as of December 31, 2024.

Operations and Business Outlook Highlights

First Quarter and Full Year 2026 Guidance

The Company’s business outlook is based on management’s current views and estimates with respect to market conditions, production capacity, the Company’s order book and the global economic environment. This outlook is subject to uncertainty on final customer demand and sale schedules. Management’s views and estimates are subject to change without notice.

For the first quarter of 2026, the Company expects its module shipments to be in the range of 13.0 GW to 14.0 GW.

For full year 2026, the Company estimates its module shipments to be in the range of 75.0 GW to 85.0 GW.

For full year 2026, the Company expects its ESS shipments to be more than doubled year-over-year.

Solar Products Production Capacity

The Company expects its annual integrated production capacity to be 100GW, including 14 GW overseas, by the end of 2026, by the end of 2026.

Recent Business Developments

• In February 2026, Jinko ESS North American business unit has received IEC 62443-2-4 certification from exida, a globally recognized authority in industrial cybersecurity and functional safety.
• In February 2026, Jiangxi Jinko published certain preliminary unaudited consolidated financial results as of and for the full year ended December 31, 2025.

Conference Call Information

JinkoSolar’s management will host an earnings conference call on Thursday, April 16, 2026 at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing / Hong Kong the same day).

Please register in advance of the conference using the link provided below. Upon registering, you will be provided with participant dial-in numbers, passcode and unique access PIN by a calendar invite.

Participant Online Registration: https://s1.c-conf.com/diamondpass/10054051-xbgjcl.html 

It will automatically direct you to the registration page of “JinkoSolar Fourth Quarter and Full Year 2025 Earnings Conference Call”, where you may fill in your details for RSVP.

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

A telephone replay of the call will be available 2 hours after the conclusion of the conference call through 23:59 U.S. Eastern Time, April 23, 2026. The dial-in details for the replay are as follows:

International: +61 7 3107 6325  
U.S.:      +1 855 883 1031 
Passcode:     10054051

Additionally, a live and archived webcast of the conference call will be available on the Investor Relations section of JinkoSolar’s website at http://www.jinkosolar.com.

About JinkoSolar Holding Co., Ltd.

JinkoSolar (NYSE: JKS) is a global leader in clean energy technology. JinkoSolar distributes its solar products and sells its solutions and services to a diversified international utility, commercial and residential customer base in China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, Netherlands, Poland, Austria, Switzerland, Greece and other countries and regions.

JinkoSolar had over 10 productions facilities globally, over 20 overseas subsidiaries in Japan, South Korea, Vietnam, India, Turkey, Germany, Italy, Switzerland, the United States, Mexico, and other countries, and a global sales network with sales teams in China, the United States, Canada, Brazil, Chile, Mexico, Italy, Germany, Turkey, Spain, Japan, the United Arab Emirates, Netherlands, Vietnam and India, as of December 31, 2025.

To find out more, please see: www.jinkosolar.com

Currency Convenience Translation

The conversion of Renminbi into U.S. dollars in this release, made solely for the convenience of the readers, is based on the noon buying rates in the city of New York for cable transfers of Renminbi as certified for customs purposes by the Federal Reserve Bank of New York as of December 31, 2025, which was RMB6.9931 to US$1.00. No representation is intended to imply that the Renminbi amounts could have been, or could be, converted, realized, or settled into U.S. dollars at that rate or any other rate. The percentages stated in this press release are calculated based on Renminbi.

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Among other things, the quotations from management in this press release and the Company’s operations and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in JinkoSolar’s filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. Except as required by law, the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

For investor and media inquiries, please contact:

In China:
Ms. Stella Wang
JinkoSolar Holding Co., Ltd.
Tel: +86 21-5180-8777 ext.7806
Email: ir@jinkosolar.com 

Mr. Christian Arnell
Christensen
Tel: +852 2117 0861
Email: christian.arnell@christensencomms.com 

In the U.S.:
Email: jinko@christensencomms.com

GUANGZHOU, China, April 16, 2026 /PRNewswire/ — Vipshop Holdings Limited (NYSE: VIPS), a leading online discount retailer for brands in China (“Vipshop” or the “Company”), today announced that the Company has filed its annual report on Form 20-F that includes its audited financial statements for the three years ended December 31, 2025 with the U.S. Securities and Exchange Commission on April 16, 2026. The annual report is available on the Company’s website at ir.vip.com. Holders of the Company’s securities may request a copy of the Company’s annual report free of charge according to the instructions provided on the Company’s website.

About Vipshop Holdings Limited

Vipshop Holdings Limited is a leading online discount retailer for brands in China. Vipshop offers high quality and popular branded products to consumers throughout China at a significant discount to retail prices. Since it was founded in August 2008, the Company has rapidly built a sizeable and growing base of customers and brand partners. For more information, please visit https://ir.vip.com/.

Investor Relations Contact

Tel: +86 (20) 2233-0732
Email: IR@Vipshop.com